Wealth Enhancement Trust Services’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Wealth Enhancement Trust Services's CORT Position: Q3 2026 in Review
Wealth Enhancement Trust Services sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 128 shares — an estimated $11.1K sold.
Wealth Enhancement Trust Services first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $11.1K in Q2 2026. 487 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Wealth Enhancement Trust Services reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Trust Services sold 128 Corcept Therapeutics shares in Q3 2026, an estimated $11.1K.
- Wealth Enhancement Trust Services first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Trust Services's Corcept Therapeutics position peaked at $11.1K in Q2 2026.
- 487 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.